BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

BioCryst Pharmaceuticals beat estimated earnings by 17.86%, reporting an EPS of $-0.23 versus an estimate of $-0.28.

Revenue was up $34.83 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 2.26% increase in the share price the next day.

Here's a look at BioCryst Pharmaceuticals's past performance:

To track all earnings releases for BioCryst Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.